Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. The Senior Global Medical Affairs Lead (GMAL) for Head and Neck cancers will be responsible for leading aspects of the optimization for our strategy and launch readiness for our assets in development in H&N cancer and its life cycle management strategies. The focus of the H&N sGMAL will be on amivantamab’s upcoming indications in HNSCC, and he/she will be responsible for the overall strategy, as well as early pipeline in H&N. As the leader of the WWMAST (Worldwide Medical Affairs Strategy team), the sGMAL will work with the Regional Medical Affairs Leaders in addressing data gaps and building confidence to ensure the most optimal and safe use of and maximize the benefit for patients. A key component of the role of the H&N sGMAL will be providing input on the unmet need and clinical impact expected from future indications, and data gaps associated with it. The sGMAL will partner closely with the GMA Operations Leader, Marketing and Market access leader, Regional Medical TA/product leaders and Clinical Development Leader to develop an integrated global medical affairs perspectives, strategies and plans. The sGMAL will partner with the regions and the extended medical affairs partners for the development of the global Medical Affairs Strategic plan (WWMAS) that reflects the medical strategy and prioritized needs. In addition, the WWMAST, led by the sGMAL will develop the Integrated Evidence Generation plan, Global Publication plans, Global Opinion Leader relations, Global Medical Education plans and Content, and will be in charge of an overall strategy for optimal Insights gathering. The sGMAL partner with the Global Commercial and Market Access Leads to develop the Global asset plan and be part of the Global Commercial Team (GCT), and Evidence & Medical Access Team. The sGMAL will represent Medical affairs for H&N at the Compound Development Team for amivantamab, which is the key strategic cross-functional team in charge of the overall strategy and life cycle of the product. Other key partners of the sGMAL include clinical development, safety, stat, coms patients advocacy, etc. as well as sGMAL for Lung and CRC. The sGMAL is responsible to ensure all global activities follow J&J Compliance principles, e.g. Health Care Compliance, etc.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree